메뉴 건너뛰기
Clinical Nuclear Medicine
Volumn 32, Issue 4, 2007, Pages 302-303
No apparent alteration of F-18 FDG biodistribution when injected shortly after insulin glargine
Author keywords

Diabetes; Insulin; PET CT imaging
Indexed keywords

FLUORODEOXYGLUCOSE F 18; INSULIN GLARGINE;
EID: 34147187306     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000257273.55996.8b     Document Type: Article
Times cited : (5)
References (8)
  • 1
    • 34147139127 scopus 로고    scopus 로고
    • Lantus insulin glargine, package insert, Bridgewater, NJ: Sanofi-Aventis; 2001
    • Lantus (insulin glargine) [package insert]. Bridgewater, NJ: Sanofi-Aventis; 2001.
  • 2
    • 22144460987 scopus 로고    scopus 로고
    • Insulin glargine: A long acting insulin analog
    • Chakkarwar PN, Manjrekar NA. Insulin glargine: a long acting insulin analog. J Postgrad Med. 2005;51:68-71.
    • (2005) J Postgrad Med , vol.51 , pp. 68-71
    • Chakkarwar, P.N.1    Manjrekar, N.A.2
  • 3
    • 0038383535 scopus 로고    scopus 로고
    • Insulin glargine: A systematic review of a long-acting insulin analogue
    • Wang F, Carabino JM, Vergara CM. Insulin glargine: a systematic review of a long-acting insulin analogue. Clin Ther. 2003;25:1541-1577.
    • (2003) Clin Ther , vol.25 , pp. 1541-1577
    • Wang, F.1    Carabino, J.M.2    Vergara, C.M.3
  • 4
    • 0033661254 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro
    • Lepore M, Pampanelli S, Fanelli C, et al. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes. 2000;49:2142-2148.
    • (2000) Diabetes , vol.49 , pp. 2142-2148
    • Lepore, M.1    Pampanelli, S.2    Fanelli, C.3
  • 5
    • 0034968761 scopus 로고    scopus 로고
    • Physiological insulin replacement in type 1 diabetes mellitus
    • Bolli GB. Physiological insulin replacement in type 1 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2001;109(Suppl 2):S317-S332.
    • (2001) Exp Clin Endocrinol Diabetes , vol.109 , Issue.SUPPL. 2
    • Bolli, G.B.1
  • 6
    • 33847225019 scopus 로고    scopus 로고
    • Insulin glargine and its place in the treatment of types 1 and 2 diabetes mellitus
    • Chatterjee S, Tringham JR, Davies MJ. Insulin glargine and its place in the treatment of types 1 and 2 diabetes mellitus. Expert Opin Pharmacother. 2006;7:1357-1371.
    • (2006) Expert Opin Pharmacother , vol.7 , pp. 1357-1371
    • Chatterjee, S.1    Tringham, J.R.2    Davies, M.J.3
  • 7
    • 0035171247 scopus 로고    scopus 로고
    • Insulin glargine: The first clinically useful extended-action insulin analogue
    • Ashwell SG, Home PD. Insulin glargine: the first clinically useful extended-action insulin analogue. Expert Opin Pharmacother. 2001;2:1891-1902.
    • (2001) Expert Opin Pharmacother , vol.2 , pp. 1891-1902
    • Ashwell, S.G.1    Home, P.D.2
  • 8
    • 33745575054 scopus 로고    scopus 로고
    • Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0
    • Delbeke D, Coleman RE, Guiberteau MJ, et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med. 2006;47:885-895.
    • (2006) J Nucl Med , vol.47 , pp. 885-895
    • Delbeke, D.1    Coleman, R.E.2    Guiberteau, M.J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.